Anna Sauerbier Selected Research

Anna Sauerbier Research Topics

16	Parkinson Disease (Parkinson's Disease) 04/2024 - 01/2016
2	COVID-19 01/2022 - 11/2021
2	Pain (Aches) 01/2021 - 09/2015
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017 - 09/2015
1	Movement Disorders (Movement Disorder) 07/2023
1	Essential Tremor (Essential Tremors) 07/2023
1	Chronic Pain 04/2022
1	Fatigue 08/2021
1	Diabetes Mellitus 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Dyskinesias (Dyskinesia) 01/2020
1	Dystonia (Limb Dystonia) 10/2019
1	Emotional Exhaustion 10/2019
1	Restless Legs Syndrome (Restless Legs) 01/2017
1	Orthostatic Hypotension (Postural Hypotension) 09/2015
1	Psychotic Disorders (Schizoaffective Disorder) 09/2015
1	Sleep Apnea Syndromes (Sleep Apnea) 09/2015

4	Levodopa (L Dopa)FDA LinkGeneric 01/2024 - 01/2017
2	Apomorphine FDA Link 08/2021 - 01/2019
2	Carbidopa (Lodosyn)FDA LinkGeneric 08/2021 - 01/2017
1	Analgesics (Analgesic Drugs)IBA 04/2022
1	VaccinesIBA 01/2022
1	benzoyl L-arginine methyl ester (BAME)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	opicaponeIBA 01/2020
1	RacloprideIBA 01/2017
1	rotigotine FDA Link 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Rivastigmine (Exelon)FDA LinkGeneric 09/2015
1	Opiate AlkaloidsIBA 09/2015
1	pimavanserinIBA 09/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2015
1	Doxepin (Mareen)FDA LinkGeneric 09/2015
1	Piribedil (Trivastal)IBA 09/2015
1	Serotonin (5 Hydroxytryptamine)IBA 09/2015
1	Solifenacin Succinate FDA Link 09/2015
1	DroxidopaIBA 09/2015

12	Deep Brain Stimulation 04/2024 - 09/2015
5	Therapeutics 04/2024 - 01/2016
3	Activities of Daily Living (ADL) 01/2024 - 10/2019
1	Analgesia 04/2022
1	Subcutaneous Infusions 08/2021
1	Transdermal Patch 01/2017
1	Continuous Positive Airway Pressure 09/2015